These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6249542)
1. Urinary adenosine 3',5'-monophosphate, circulating amino-terminal PTH (1--34) and carboxyl-terminal PTH in hypoparathyroidism. Tomita A; Konagaya Y; Nakagawa H Contrib Nephrol; 1980; 22():59-67. PubMed ID: 6249542 [TBL] [Abstract][Full Text] [Related]
2. Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism. Bell NH; Avery S; Sinha T; Clark CM; Allen DO; Johnston C J Clin Invest; 1972 Apr; 51(4):816-23. PubMed ID: 4335445 [TBL] [Abstract][Full Text] [Related]
3. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract. Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700 [TBL] [Abstract][Full Text] [Related]
4. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism. Coulson R; Moses AM J Pharmacol Exp Ther; 1975 Sep; 194(3):603-13. PubMed ID: 169346 [TBL] [Abstract][Full Text] [Related]
6. [Urinary phosphate and cyclic adenosine monophosphate response to intravenous administration of synthetic human parathyroid hormone-(1-34) in idiopathic hypoparathyroidism, pseudohypoparathyroidism, pseudopseudohypoparathyroidism and normal subjects]. Fukami T; Fujita T; Yoshimoto Y; Fukase M; Imai Y; Sakaguchi K; Ogata E; Furukawa Y; Suzuki H; Takebe K Nihon Naibunpi Gakkai Zasshi; 1984 Mar; 60(3):159-70. PubMed ID: 6090236 [TBL] [Abstract][Full Text] [Related]
7. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism. Mizunashi K; Furukawa Y; Abe K; Yoshinaga K Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350 [TBL] [Abstract][Full Text] [Related]
8. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)]. Stögmann W Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830 [TBL] [Abstract][Full Text] [Related]
9. [Chronic idiopathic hypoparathyroidism: report of 3 cases]. Alvarez Aparicio E; Prieto Veiga J; Blázquez García J; de Manueles Jiménez J; Palomero Elorduy B; Herrera Criado F; Salazar Villalobos V An Esp Pediatr; 1985 Apr; 22(5):402-6. PubMed ID: 2990273 [TBL] [Abstract][Full Text] [Related]
10. Renal-resistant hormonoplethoric hypoparathyroidism with evidence for a defective response to cAMP. Duck SC; Rosenberg EM; Ratzan SK; Haymond MW J Clin Endocrinol Metab; 1978 Sep; 47(3):640-6. PubMed ID: 233678 [TBL] [Abstract][Full Text] [Related]
11. Effect of calcium administration on renal responsiveness to parathyroid hormone in pseudohypoparathyroidism type I and II -- in comparison with normals, idiopathic and surgical hypoparathyroidism. Yamada K; Tamura Y; Yamamoto M; Kumagai A Endocrinol Jpn; 1979 Apr; 26(2):147-57. PubMed ID: 225161 [TBL] [Abstract][Full Text] [Related]
12. Urinary and nephrogenous cyclic AMP and renal phosphate handling in normal subjects and patients with parathyroid dysfunction. Khoury S; Tucci JR Acta Endocrinol (Copenh); 1984 Jun; 106(2):219-26. PubMed ID: 6328823 [TBL] [Abstract][Full Text] [Related]
13. The renal response to exogenous parathyroid hormone in treated pseudohypoparathyroidism. Stone MD; Hosking DJ; Garcia-Himmelstine C; White DA; Rosenblum D; Worth HG Bone; 1993; 14(5):727-35. PubMed ID: 8268047 [TBL] [Abstract][Full Text] [Related]
14. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia. Shaw JW; Oldham SB; Rosoff L; Bethune JE; Fichman MP J Clin Invest; 1977 Jan; 59(1):14-21. PubMed ID: 187621 [TBL] [Abstract][Full Text] [Related]
15. Renal cyclic adenosine monophosphate: an accurate index of parathyroid function. Drezner MK; Neelon FA; Curtis HB; Lebovitz HE Metabolism; 1976 Oct; 25(10):1103-12. PubMed ID: 184364 [TBL] [Abstract][Full Text] [Related]
16. [Pseudo-idiopathic hypoparathyroidism]. Playán Usón J; Sanz Paris A; Bosque Peralta MT; Trincado Aznar P; Acha Peréz J; Albero Gamboa R An Med Interna; 1996 Jun; 13(6):288-90. PubMed ID: 8962961 [TBL] [Abstract][Full Text] [Related]
17. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism. Neer RM; Tregear GW; Potts JT J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258 [TBL] [Abstract][Full Text] [Related]
18. [Effects of synthetic human parathyroid hormone (1-34) on plasma and urinary adenosine 3',5'-monophosphate and urinary phosphate and calcium in patients with hypoparathyroidism and pseudohypoparathyroidism (author's transl)]. Konagaya Y; Takatsuki K; Tomita A Nihon Naibunpi Gakkai Zasshi; 1981 Nov; 57(11):1591-608. PubMed ID: 6276237 [No Abstract] [Full Text] [Related]
19. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH. Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082 [TBL] [Abstract][Full Text] [Related]
20. Grouping of patients with hyperparathyroidism by clinical signs, correlated to some biochemical findings. Andersson R; Gillquist J; Larsson L; Kågedal B Acta Chir Scand; 1976; 142(8):567-73. PubMed ID: 202128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]